Stroke Prevention in Subclinical Atrial Fibrillation. Reply.
Publication
, Journal Article
Healey, JS; Lopes, RD
Published in: N Engl J Med
April 18, 2024
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
N Engl J Med
DOI
EISSN
1533-4406
Publication Date
April 18, 2024
Volume
390
Issue
15
Start / End Page
1442
Location
United States
Related Subject Headings
- Stroke
- Pyridones
- Pyrazoles
- Humans
- General & Internal Medicine
- Atrial Fibrillation
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Healey, J. S., & Lopes, R. D. (2024). Stroke Prevention in Subclinical Atrial Fibrillation. Reply. N Engl J Med, 390(15), 1442. https://doi.org/10.1056/NEJMc2401632
Healey, Jeff S., and Renato D. Lopes. “Stroke Prevention in Subclinical Atrial Fibrillation. Reply.” N Engl J Med 390, no. 15 (April 18, 2024): 1442. https://doi.org/10.1056/NEJMc2401632.
Healey JS, Lopes RD. Stroke Prevention in Subclinical Atrial Fibrillation. Reply. N Engl J Med. 2024 Apr 18;390(15):1442.
Healey, Jeff S., and Renato D. Lopes. “Stroke Prevention in Subclinical Atrial Fibrillation. Reply.” N Engl J Med, vol. 390, no. 15, Apr. 2024, p. 1442. Pubmed, doi:10.1056/NEJMc2401632.
Healey JS, Lopes RD. Stroke Prevention in Subclinical Atrial Fibrillation. Reply. N Engl J Med. 2024 Apr 18;390(15):1442.
Published In
N Engl J Med
DOI
EISSN
1533-4406
Publication Date
April 18, 2024
Volume
390
Issue
15
Start / End Page
1442
Location
United States
Related Subject Headings
- Stroke
- Pyridones
- Pyrazoles
- Humans
- General & Internal Medicine
- Atrial Fibrillation
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences